These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014-2019. Abdrabou AMM, Ul Habib Bajwa Z, Halfmann A, Mellmann A, Nimmesgern A, Margardt L, Bischoff M, von Müller L, Gärtner B, Berger FK. Int J Med Microbiol; 2021 May; 311(4):151507. PubMed ID: 33915347 [Abstract] [Full Text] [Related]
13. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain. Weber I, Riera E, Déniz C, Pérez JL, Oliver A, Mena A. Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477 [Abstract] [Full Text] [Related]
14. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China. Cheng JW, Yang QW, Xiao M, Yu SY, Zhou ML, Kudinha T, Kong F, Liao JW, Xu YC. J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926 [Abstract] [Full Text] [Related]
15. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017. Tickler IA, Obradovich AE, Goering RV, Fang FC, Tenover FC, HAI Consortium. Anaerobe; 2019 Dec; 60():102050. PubMed ID: 31173889 [Abstract] [Full Text] [Related]
17. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021. Abdrabou AMM, Bischoff M, Mellmann A, von Müller L, Margardt L, Gärtner BC, Berger FK, German C. difficile surveillance group. Anaerobe; 2022 Oct; 77():102548. PubMed ID: 35307546 [Abstract] [Full Text] [Related]